Sareum Holdings Investor Relations Material
Latest events
H1 2025
Sareum Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Sareum Holdings plc
Access all reports
Sareum Holdings plc is a UK-based biotechnology company focused on the discovery and development of small molecule therapeutics targeting cancer and autoimmune diseases. The company specializes in kinase inhibition and advances its drug candidates through preclinical and early clinical development stages. Sareum’s lead programs target immune and inflammation pathways, and the company collaborates with partners to support further development and commercialization. Sareum Holdings plc is headquartered in Cambridge, United Kingdom, and its shares are listed on the AIM.
Key slides for Sareum Holdings plc
H2 2024
Sareum Holdings plc
H1 2025
Sareum Holdings plc
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
SAR
Country
🇬🇧 United Kingdom